Assuming patients is required, the following results were found.

  • Mindfulness training may be helpful in more than one way for people with MS

    Reviewed by Emily Henderson, B.Sc.May 18 2020 New research suggests mindfulness training may help multiple sclerosis patients in two very different ways: regulating negative emotions and improving processing speed. People with MS who underwent the...

    https://mschristian.org/index.php/mindfulness-training-may-be-helpful-in-more-than-one-way-for-people-with-ms
  • #ECTRIMS2019 - Are Injectables Inappropriate for Active Relapsing MS? - Multiple Sclerosis News Today

    process. Kobelt led a large study looking at the cost-effectiveness of MS treatments in Europe, which included 16,808 patients, approximately half of whom had relapsing-remitting MS (RRMS). Results showed that costs and utility (meaning the patient’s...

    https://mschristian.org/index.php/blog/ectrims2019-are-injectables-inappropriate-for-active-relapsing-ms-multiple-sclerosis-news-today
  • Cannabis-based drug in combination with other anti-spasticity

    Oral spray containing two compounds derived from the cannabis plant reduced spasticity compared with placebo in patients already taking anti-spasticity drugs. Chemical compounds derived from the cannabis sativa plant given as an add-on treatment may...

    https://mschristian.org/index.php/articles/2-uncategorised/4679-cannabis-based-drug-in-combination-with-other-anti-spasticity
  • Siponimod Delays Time to Wheelchair in Secondary Progressive MS - Neurology Times

    the EXPAND study population has suggested that siponimod (Mayzent, Novartis) may have an additional long-term benefit for patients with secondary progressive multiple sclerosis (MS) beyond the study’s core findings. The oral selective...

    https://mschristian.org/index.php/articles/2-uncategorised/8782-siponimod-delays-time-to-wheelchair-in-secondary-progressive-ms-neurology-times
  • Puzzling It Out - a Podcast series for MS Patients

    "Thoughts and Perspectives from a Clinical Psychologist" Click the banner to view a podcast series created for MS Patients. Visit our MS Learning Channel on YouTube: http://www.youtube.com/msviewsandnews Original link (Originally posted by Stuart) Read...

    https://mschristian.org/index.php/articles/2-uncategorised/8791-puzzling-it-out-a-podcast-series-for-ms-patients
  • Right as Rain: Invisible Illnesses - Chapelboro.com

    of video shoots for my client, the Carcinoid Cancer Foundation. They help raise awareness, educate people, and connect patients of neuroendocrine and carcinoid tumors to specialists around the world. It’s an incredible community of people bound together...

    https://mschristian.org/index.php/blog/right-as-rain-invisible-illnesses-chapelboro-com
  • New insights into how immune system and inflammation play a role in PD

    into ways in which the immune system and inflammation can play a role in PD. The inflammatory processes that occur in some patients with PD have naturally led to discussion of an association between IBD and PD since the two share some basic...

    https://mschristian.org/index.php/blog/new-insights-into-how-immune-system-and-inflammation-play-a-role-in-pd
  • Multiple sclerosis drug slows brain shrinkage, study finds

    to investigate whether ibudilast was better than placebo in reducing the progression of brain atrophy, or shrinkage, in patients with progressive multiple sclerosis. In the study, 255 patients were randomized to take up to 10 capsules of ibudilast or...

    https://mschristian.org/index.php/blog/multiple-sclerosis-drug-slows-brain-shrinkage-study-finds
  • Studies Report on Efforts to Optimize Rituximab in MS, NMOSD - The Center for Biosimilars

    to anti-CD20 therapy, but despite the common use of the drug in neurology, there are few data that help guide individual patients’ treatment with rituximab. Important questions remain, such as how long a patient should ideally be treated with rituximab,...

    https://mschristian.org/index.php/blog/studies-report-on-efforts-to-optimize-rituximab-in-ms-nmosd-the-center-for-biosimilars
  • #ECTRIMS2019 - Transplanting MSCs Safe, Helps Stop Progressive MS - Multiple Sclerosis News Today

    from a single-center clinical trial conducted in Israel. Six months after the transplant, a considerable proportion of patients showed no signs of disease activity, compared to placebo treatment. The findings were shared at the 35th Congress of the...

    https://mschristian.org/index.php/blog/ectrims2019-transplanting-mscs-safe-helps-stop-progressive-ms-multiple-sclerosis-news-today
  • L-Methylfolate: Augmenting Agent May Contribute to Agitation and Mania - Psychiatric Times

    L-methylfolate is commonly presented as a safe augmenting agent to patients with antidepressant non-response in unipolar depression with virtually no side effects. Although this is likely to be true most of the time, as with any treatment, there are...

    https://mschristian.org/index.php/blog/l-methylfolate-augmenting-agent-may-contribute-to-agitation-and-mania-psychiatric-times
  • Economic Factors Amplify Burden of Disease for Patients With Multiple Sclerosis

    systems, a universal concern is that multiple sclerosis (MS) is a costly disease that exerts a significant burden on patients, families, and society as a whole. Speaking at the ECTRIMS 2019 Congress in Stockholm, health economist Gisela Kobelt, PhD,...

    https://mschristian.org/index.php/articles/2-uncategorised/8610-economic-factors-amplify-burden-of-disease-for-patients-with-multiple-sclerosis
  • Johns Hopkins researchers identify new way to lower blood pressure in obese patients

    are related to poorly controlled blood pressure. We've identified what may be a new way to lower blood pressure in obese patients and improve these outcomes." Vsevolod Polotsky, M.D., Ph.D., professor of medicine at the Johns Hopkins University School...

    https://mschristian.org/index.php/articles/2-uncategorised/8727-johns-hopkins-researchers-identify-new-way-to-lower-blood-pressure-in-obese-patients
  • New treatment shows promise to reverse celiac disease

    to induce immune tolerance to gluten in individuals with celiac disease. The findings may pave the way for treated celiac patients to eventually tolerate gluten in their diet. After treatment with the technology, the patients were able to eat gluten...

    https://mschristian.org/index.php/articles/2-uncategorised/8995-new-treatment-shows-promise-to-reverse-celiac-disease
  • CMSC INforMS: Use of DMTs Changing ‘Natural History’ of Relapsing MS, Study Says

    20 years ago, according to a retrospective study. The study, “Outcomes in a Modern Cohort of Treated Multiple Sclerosis Patients Followed from Diagnosis Up to 15 Years,” was published in the International Journal of MS Care. “Before disease-modifying...

    https://mschristian.org/index.php/articles/2-uncategorised/9867-cmsc-informs-use-of-dmts-changing-natural-history-of-relapsing-ms-study-says
  • New insights into how immune system and inflammation play a role in PD

    into ways in which the immune system and inflammation can play a role in PD. The inflammatory processes that occur in some patients with PD have naturally led to discussion of an association between IBD and PD since the two share some basic...

    https://mschristian.org/index.php/articles/2-uncategorised/9293-new-insights-into-how-immune-system-and-inflammation-play-a-role-in-pd
  • Stem cell transplant reverses disabling MS-like disease - Medical Xpress

    Credit: CC0 Public Domain A stem cell transplant reversed a debilitating neurological disease that causes half of the patients to go blind and lose the ability to walk five years after diagnosis. Most of the patients stayed better five years after the...

    https://mschristian.org/index.php/articles/2-uncategorised/8856-stem-cell-transplant-reverses-disabling-ms-like-disease-medical-xpress
  • Nicotine Patches Tested on Coronavirus Patients

    Credit: Sandhills French researchers are planning to test nicotine patches on coronavirus patients and frontline workers following a study suggesting smokers are less likely to catch the virus according to The Guardian. The Paris-based study suggests...

    https://mschristian.org/index.php/blog/nicotine-patches-tested-on-coronavirus-patients
  • Long term effect of delayed treatment on disability in patients with paediatric onset multiple sclerosis: A prospective Danish cohort study.

    METHODS: Based on prospectively collected data from The Danish Multiple Sclerosis Registry, we defined a cohort of MS patients with onset before the age of 18 years, who were born in 1980 or later, and started treatment with a DMT between 1998 and 2018....

    https://mschristian.org/index.php/blog/long-term-effect-of-delayed-treatment-on-disability-in-patients-with-paediatric-onset-multiple-sclerosis-a-prospective-danish-cohort-study
  • Hopes for Novel Stroke Drug Dashed in Trial

    LOS ANGELES -- A putative neuroprotective agent failed to improve stroke patients' outcomes when given in conjunction with endovascular thrombectomy in the ESCAPE-NA1 trial, although those not given a thrombolytic did appear to benefit. Nerinetide led...

    https://mschristian.org/index.php/blog/hopes-for-novel-stroke-drug-dashed-in-trial

Results 81 - 100 of 452